POSTER SESSION I

STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, March 9, 2009   —  9:30 AM - 12:00 Noon
Hynes Convention Center, Hall C/D


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




GENITOURINARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
109 Novel Biomarkers Expression in Patients with Superficial and Minimally Invasive Urothelial Bladder Cancer and Their Assoaciation with Tumor Outcomes (701)
L Ali, FR Herrmann, RT Cheney, P Mhawech-Fauceglia - Roswell Park Cancer Institiute, Buffalo, NY; University of Geneva, Geneva, Switzerland
Add
110 Pathologic Features of Salvage Radical Prostatectomy Specimens Following Radiotherapy: Implications for Focal Therapeutic Options (707)
L Andino, C Guo, E Chiong, IN Prokhorova, LL Pisters, P Troncoso - UT MD Anderson Cancer Center, Houston, TX
Add
111 Renal Carcinomas Arising in Patients with Autosomal Dominant Polycystic Kidney Disease: A Clinicopathological Review (710)
S Bai, O Hameed - University of Alabama School of Medicine, Birmingham, AL
Add
112 Smoothelin Expression Is a Useful Adjunct for Assessing Muscularis Propria Invasion in Bladder Cancer (720)
IM Bovio, SZ Al-Quran, PA Drew, RW Allan - University of Florida, Gainesville, FL
Add
113 Primary Vascular Tumors of the Kidney: A Clinicopathologic Analysis of 26 Cases (721)
JG Brown, MB Amin, P Rao, AJ Lazar, GP Paner, R Gupta, JC Cheville, AL Folpe - Cedars-Sinai Medical Center, Los Angeles, CA; MD Anderson Cancer Center, Houston, TX; Loyola University Medical Center, Maywood, IL; Mayo Clinic, Rochester, MN
Add
114 P16 Expression Can Not Be Used To Differentiate between Squamous Cell Carcinomas of Uterine Cervix and Urinary Bladder (731)
M Cioffi-Lavina, J Chapman-Fredricks, C Gomez-Fernandez, M Jorda - University of Miami Miller School of Medicine and UMSylvester Comprehensive Cancer Center, Miami, FL
Add
115 Carbonic Anhydrase IX as a Novel Target for Cytological Detection and Therapy of Low Grade Urothelial Cell Carcinoma (732)
JL Clebanoff, D Lung, M Noe, A Pantuck, P Fung, J Rao - University of California, Los Angeles, CA
Add
116 Estrogen and Progesterone Receptor Positive Stroma in Pediatric Cystic Renal Dysplasia: An Immunohistochemical Study of 18 Cases (735)
J Coviello-Malle, JK McKenney, A Heerema-McKenney - UAMS, Little Rock, AR; Stanford, Stanford, CA
Add
117 Invasive Urothelial Carcinoma with Chordoid Features: A Clinicopathologic Study of 12 Cases (736)
RM Cox, AG Schneider, AR Sangoi, WJ Clingan, N Gokden, JK McKenney - UAMS, Little Rock, AR; Stanford University, Stanford, CA
Add
118 Primary Urethral Adenocarcinomas: A Clinicopathological Review (740)
VL Dailey, PA Humphrey, O Hameed - University of Alabama at Birmingham, Birmingham, AL; Washington University School of Medicine, St. Louis, MO
Add
119 Characterization of New Immunohistochemical Markers of Renal Angiomyolipoma (752)
LJ Eisengart, AV Yeldandi, M Zhou, BT Teh, XJ Yang - Northwestern Memorial Hospital, Chicago, IL; Cleveland Clinic, Cleveland, OH; Van Andel Institute, Grand Rapids, MI
Add
120 Prostatic Adenocarcinoma and Status of Resection Margin of Radical Prostatectomy Associated with Core Biopsies with Atypical Small Acinar Proliferation or Minimal Cancer (761)
TA Flood, BN Nguyen, EC Marginean, BM Purgina, KT Mai - The Ottawa Hospital and The University of Ottawa, Ottawa, ON, Canada
Add
121 Comprehensive Assessment of TMPRSS2 and ETS Family Molecular Aberrations in Histologic Variants of Prostate Carcinoma (773)
B Han, R Mehra, N Palanisamy, K Suleman, M Zhou, AM Chinnaiyan, RB Shah - University of Michigan, Ann Arbor, MI; Cleveland Clinic, Cleveland, OH
Add
122 Can Apical Prostatic Adenocarcinoma at Biopsy Stratify Patients for Ablative Therapies? (778)
RC Heintzelman, X Chen, J Jaffe, FU Garcia - Drexel University College of Medicine, Philadelphia, PA
Add
123 Differential Expression of Dicer in Oncocytomas, Papillary, Clear Cell and Chromophobe Renal Cell Carcinomas (782)
S Hooda, M Acquafondata, R Dhir, AV Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA
Add
124 Increased Lef1 Expression in Metastatic Prostate Cancer (783)
H Huang, Y Li, J Melamed, P Lee, A de las Morenas - Boston University School of Medicine, Boston, MA; New York University School of Medicine, New York, NY
Add
125 Nuclear Expression of SOX9 Protein as a Prognostic Marker in Invasive Bladder Urothelial Carcinomas: A Tissue Microarray Immunohistochemistry Study (803)
TK Lee, R Albadine, S Jadallah, M Nielsen, SZ Ling, M Gonzalgo, DM Berman, GJ Netto - Johns Hopkins Hospital, Baltimore, MD
Add
126 The Status of Positive Surgical Margin at Radical Prostatectomy and Risk of Biochemical Recurrence: A Single Institution Experience (805)
M Li, J Song, S Shikanov, S Eggnener, A Shalhav, J Taxy, H Al-Ahmadie - University of Chicago, Chicago, IL
Add
127 Insulin-Like Growth Factor Binding Protein 3 Is Up-Regulated in Prostatic Adenocarcinoma and Correlates with Gleason Grade (808)
KD Linos, S Lu, JS Ross, TA Jennings, BM Mian, HAT Nazeer, CE Sheehan, T Nazeer - Albany Medical College, Albany, NY
Add
128 Patients with Recurrent Prostate Adenocarcinoma Show Higher Levels of Somatostatin Receptor 2 Expression (816)
NE Lueck, CM Simons, RD Williams, TM O'Dorisio, MS O'Dorisio, BR DeYoung - University of Iowa Hospitals and Clinics, Iowa City, IA
Add
129 Assessment of Utility of TMPRSS2: ERG Gene Aberrations To Predict Salvage Radiotherapy Prostate Cancer Outcomes (824)
R Mehra, B Han, RJ Lonigro, K Suleman, SA Tomlins, N Palanisamy, DA Hamstra, AM Chinnaiyan, RB Shah - University of Michigan, Ann Arbor, MI
Add
130 TMPRSS2-ERG Gene Rearrangement Is Associated with C-MYC Protein Over-Expression in Prostate Cancer (826)
R Merha, SA Tomlins, RJ Lonigo, L Wang, A Menon, RB Shah, AM Chinnaiyan - University of Michigan, Ann Arbor, MI
Add
131 Small Cell Carcinoma of the Renal Pelvis and Ureter: Clinicopathologic and Immuno-histochemical Features (832)
R Miller, SM Lele, S Holmang, S Johansson - University of Nebraska Medical Center, Omaha, NE; Sahlgrenska University Hospital, Goteborg, Sweden
Add
132 Fluorescence In Situ Hybridization Assay for ERG Gene Disruption in Acinar (PCA-A) and Ductal (PCA-D) Subtypes of Prostatic Adenocarcinoma (846)
LA Niemeier, K Cieply, R Dhir, AV Parwani, K Cumbie, C Sherer, J Salvatore, M Youschak, A Perepletchikov, G Cai, L Kiss, SI Bastacky - University of Pittsburgh Medical Center, Pittsburgh, PA
Add
133 IFI16 Protein: A Potential Molecular Marker in Prostate Cancer: From Molecular Lab to the Pathology Lab (863)
JP Reynolds, HX Bui, H Al-Ghawi, GA Hill, R Panchananthan, D Choubey - VAMC & U of Cincinnati, Cincinnati, OH
Add
134 Renal Cancer in Tuberous Sclerosis: An Underdiagnosed Disease? Molecular, IHC and Pathologic Correlation (866)
SR Chowdhuri, J Vicens, L Teller, WM Linehan, MJ Merino - National Cancer Institute, Bethesda, MD
Add
135 Decreased Expression of CD38 in High Grade Prostate Cancer (868)
JL Schmidt, AT Johnson (co-first author), SC Schmechel - University of Minnesota, Minneapolis, MN
Add
136 Significant Inhibition of Tumor-Suppressor Genes in Renal Cell Carcinoma (872)
SR Scrape, H Zhang, C Xie, N Gokden, CY Fan - University of Arkansas for Medical Sciences, Little Rock, AR; John L. McClellan Memorial Veterans Hospital, Little Rock, AR
Add
137 The Value of Intraoperative Assessment of Pelvic Lymph Nodes during Radical Prostatectomy (880)
J Song, J Taxy, H Al-Ahmadie - University of Chicago, Chicago, IL
Add
138 Differential Expression of Heterochromatin Protein 1 in Renal Cortical Tumors (897)
M Tretiakova, A Contreras, H Al-Ahmadie - University of Chicago, Chicago, IL
Add
139 MicroRNA Expression Profiling Distinguishes Conventional and Chromophobe Renal Cell Carcinomas from Normal Renal Parenchyma (928)
DL Zynger, WA LaFramboise, JM Krill-Burger, CM Sciulli, AM Hensler, AM Perepletchikov, LP Kiss, R Dhir, G Cai, AV Parwani, SI Bastacky - University of Pittsburgh Medical Center, Pittsburgh, PA
Add